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Multimodal neuroimaging in presurgical evaluation of 
childhood epilepsy
In pre-surgical evaluation of pediatric epilepsy, the combined use of 
multiple imaging modalities for precise localization of the epileptogenic 
focus is a worthwhile endeavor. Advanced neuroimaging by high field 
Magnetic resonance imaging (MRI), diffusion tensor images, and MR 
spectroscopy have the potential to identify subtle lesions. 18F-FDG 
positron emission tomography and single photon emission tomography 
provide visualization of metabolic alterations of the brain in the ictal 
and interictal states. These techniques may have localizing value for 
patients which exhibit normal MRI scans. Functional MRI is helpful for 
non-invasively identifying areas of eloquent cortex. These advances are 
improving our ability to noninvasively detect epileptogenic foci which 
have gone undetected in the past and whose accurate localization is 
crucial for a favorable outcome following surgical resection.
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Introduction
Surgery for treatment of epilepsy has emerged as an important 
option for treatment of children with epilepsy that is refractory 
to antiepileptic drug management. The causes of intractable 
childhood epilepsy are quite variable, and in pediatric candidates 
for epilepsy surgery, focal cortical dysplasia (FCD) is the 
predominant etiology1). A presurgical evaluation starts with a 
complete seizure history, physical and neurological examinations, 
video-EEG monitoring, and high-resolution magnetic resonance 
imaging (MRI) of the brain to assess structural abnormalities2). 
These investigations are complemented by interictal and ictal 
single photon emission tomography (SPECT) injection, interictal 
18F-fluorodeoxyglucose (FDG) positron emission tomography 
(PET), and neuropsychological examination. The cornerstone 
of successful surgery is accurate localization of the brain region 
responsible for the onset of seizure. Modern imaging techniques 
have therefore been improved for the detection of epileptogenic 
lesions, which frequently evolve to secondary generalized epileptic 
encephalopathy3). 
In this review, we describe the current role of structural and 
functional brain imaging modalities for presurgical evaluation of 
patients with intractable childhood epilepsy with a focus on FCD. 
Structural neuroimaging
MRI is an essential neuroimaging tool which is used to assist in 
the identification of an epileptogenic substrate. FCD is a common 
cause of pharmacoresistant epilepsy that is amenable to surgical 
resective treatment. The identification of structural FCD by MRI 
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can contribute to the detection of the epileptogenic zone and 
improve the outcome of epilepsy surgery. MRI epilepsy protocols 
that include specific T1 and T2 weighted, and fluid-attenuated 
inversion recovery (FLAIR) sequences give complementary 
information about the characteristic imaging features of FCD; 
focal cortical thickening, blurring of the gray-white junction, high 
FLAIR signal, and gyral anatomical abnormalities4). Conventional 
spin-density or fast multiplanar inversion-recovery images may 
give better delineation of the gray-white interface5). The heavily 
T2-weighted FLAIR sequence enables detection of more subtle 
signal abnormalities in the superficial cortical, subcortical, and 
periventricular regions due to suppression of the cerebrospinal fluid 
(CSF) signal. Limitations of the FLAIR technique include the 
occurrence of CSF pulsation artifacts in the basilar cisterns, relative 
suppression of contrast between gray and white matter, and limited 
usefulness in children under the age of 2 years (whose images 
may show patchy areas of hyperintensity within normal white 
matter)6). The use of gadolinium diethylenetriamine-pentaacetic 
acid (Gd-DTPA) contrast agents does not provide additional 
information in the evaluation of FCD. Information derived from 
the patient’s history and video-EEG monitoring is often used in 
the interpretation of imaging studies and this information may 
be used to modify the MRI protocol, for example, to provide thin 
cuts through the suspected lobe of origin7). In the presence of FCD, 
however, removal of the visible lesion alone frequently does not lead 
to freedom from seizures. This indicates that the epileptogenic zone 
extends beyond the tissue which can be visualized with current 
structural imaging modalities. For this reason, there has been 
ongoing interest in utilizing new advanced MRI techniques to 
improve our ability to identify subtle lesions of cortical dysplasias. 
Technological advances such as the development of multichannel 
coils (32 phased array and beyond) and higher magnetic field 
strengths (3 T, 7 T, and greater) are likely to increase yield. The 3 
T scans revealed different lesions which were not visible in the 1.5 
T scans. Patients can benefit most from 3 T scans when a dysplasia 
is suspected8) . The combination of 3 T and scans with the use of a 
specific phased-array head coil further increases the visualization of 
an MRI abnormality in presurgical epilepsy evaluation9). 
Functional Neuroimaging
Functional imaging detects changes in cerebral metabolism or 
cerebral perfusion in the interictal or ictal state. Nuclear medicine 
plays an important role in the presurgical assessment of patients 
with refractory epilepsy. Correct localization of the ictal onset zone 
with the use of SPECT or PET is associated with an improved 
surgical outcome. Quantitative processing of structural MR data 
and advanced MRI such as diffusion tensor imaging and MR 
spectroscopy have the potential to identify subtle lesions. 
1. Positron-emission tomography (PET)
Hypometabolism identified by FDG-PET has been ascribed 
to factors such as neuronal loss, diaschisis, inhibitory processes, 
reduction in synaptic density, or decreased blood–brain barrier 
glucose transporter activity10-12). Interictal 18F-FDG-PET is 
routinely used to detect brain areas of hypometabolism, which 
usually encompass the seizure onset zone and can also extend 
beyond this zone13). Thus, 18F-FDG PET has lateralizing rather 
than localizing value in temporal lobe epilepsy (TLE). However, 
because of the poor resolution of this imaging modality, the focus 
may in fact be at the margin of the area of hypometabolism. A 
recent report14) has demonstrated that co-registering or fusing 
the PET data with the structural MRI can improve the ability to 
identify subtle cortical dysplasias. Such studies have demonstrated 
that in patients with previously MR-negative test results, the fusion 
information helped to identify lesions, guide surgical planning, and 
improve overall surgical outcomes. The presence of contralateral 
cortical hypometabolism predicts a low chance of seizure freedom 
after temporal lobectomy15) and the extent of resection of brain areas 
with hypometabolism on FDG-PET is correlated with improved 
seizure outcome16). The localizing value of FDG-PET in neocortical 
epilepsy was significantly worse in patients with extratemporal 
epilepsy, relative to patients with TLE17). Also, for assessment of 
FDG-PET, it is advisable to use an automated technique to compare 
the patient’s images to normal data images in a database in addition 
to visual interpretation of the images, since automated techniques 
have proven to be more accurate. A semi-automated method for 
assessment of asymmetries in the brain cortex was developed which 
compares activity concentrations in homotopic cortical areas18). 
When these differences exceed a predefined threshold, the areas 
with lower activity are marked and 3-dimensional surface rendered 
images are created to guide placement of intracranial electrodes 
(ECoG). This step is followed by surgical resection. The sensitivity-
specificity pairs for correct localization of epileptogenic lobes based 
on the ECoG results were found to be best for the 15% threshold 
(80/94%, accuracy 0.90)18). This objective PET method enables 
accurate determination of cortical asymmetries, and it has proven 
to be highly efficient in guiding epilepsy surgery. 
Although 18FDG, a glucose analog, has been the most 
common radiotracer nuclide used in PET imaging, it is possible 
to perform PET imaging with other radiotracers. For example, 
flumazenil, a benzodiazepine antagonist that acts as a competitive 
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inhibitor against the γ-aminobutyric acid (GABA)A receptor, 
can be labeled with a 11carbon (11C) radiotracer which has a 
considerably shorter half-life. Because GABAA is the principal 
inhibitory neurotransmitter in the brain, its role in epilepsy is of 
ongoing interest. Reports have suggested that, relative to 18FDG-
PET, f lumazenil provides improved localization and better 
correlation with the epileptogenic focus19, 20). Another ligand of 
interest is 11C-alpha-methyl-l-tryptophan (11C-AMT), an analog 
of tryptophan and a precursor to serotonin. This ligand has also 
been reported to be specific for differentiating epileptogenic from 
nonepileptogenic foci in patients with intractable epilepsy with 
or without tuberous sclerosis complex21). Resection of tubers with 
increased AMT uptake is highly desirable to achieve a seizure-
free surgical outcome in children with tuberous sclerosis complex 
and intractable epilepsy. AMT PET can provide independent 
complementary information regarding the localization of 
epileptogenic regions in tuberous sclerosis complex and enhance 
the confidence of patient selection for successful epilepsy surgery22). 
The combination of some of these or other novel radioligands with 
PET-MRI technology may increase the rate of detection of FCD. 
However, these tracers are not widely available and the superiority 
of studying these receptor systems over glucose metabolism in the 
presurgical evaluation of patients with refractory epilepsy remains 
to be proven. Their use in clinical practice is currently limited23). 
2. Single Photon Emission Computed Tomography 
(SPECT)
Ictal SPECT typically indicates areas of regional hyperperfusion, 
which reflects relative hypermetabolism in parts of the brain 
involved in onset or propagation of seizure24). Subtraction of 
the interictal images from the ictal images and co-registration 
to the patient’s MRI (SISCOM) improves the interpretation of 
the study25). SISCOM has proven to be more sensitive and more 
specific compared with visual assessment. The importance of 
early tracer injection after the beginning of the seizure cannot 
be overemphasized. It has been shown that an injection delay 
of less than 20 seconds is significantly correlated with a correct 
localization. With early injections, the largest and most intense 
cluster is more likely to represent the seizure onset zone and not 
propagation of the seizure26). The interpretation of automatically-
generated SISCOM data is generally straightforward. The result 
of the SISCOM analysis must be concordant with the result of 
the visual comparison of the ictal and interictal images, and other 
data related to the presurgical evaluation. Furthermore, SISCOM 
may provide a false negative test result because of subclinical 
seizure activity at the moment of tracer injection for interictal 
SPECT imaging26). Therefore, EEG monitoring during the 
interictal injection should be routinely performed. PET results were 
similarly reliable in lateralizing the temporal epileptic area, while its 
efficacy was lower for extratemporal cases. SISCOM was found to 
effectively localize lesions in extratemporal cases, but its efficacy is 
lower in temporal lesions27).
3. Magnetic resonance spectroscopy (MRS)
Reduced 1H-MRS N-acetyl aspartate over choline (NAA/
Cho) and N-acetyl aspartate over creatine (NAA/Cr) have 
been demonstrated in FCD. Large increases in GABA, alanine, 
tyrosine, acetate, inositol, glucose, and lactate, as well as decreased 
NAA were found in a group of four patients with “mild” cortical 
dysplasia28). These findings may ref lect underlying regional 
structural abnormalities under the resolution of conventional 
MRI. Alternatively, decreases in N-acetyl aspartate may reflect 
neuronal or glial cell dysfunction29). The clinical utility of MRS 
in the evaluation of FCD is not known because MRS is limited 
by spatial sampling and the above findings are non-specific for 
FCD. Reduced NAA/Cho ratios outside the epileptogenic region 
have been reported in temporal lobe epilepsy, and correlate with 
reductions in seizure-free outcomes after surgery30). However, there 
are no data supporting this observation in an FCD setting. The 
sensitivity and specificity of MRS for detecting FCD has not been 
systematically studied. In another study, preoperative reductions 
in the NAA/Cr ratio in the non-operated temporal lobe or the 
presence of higher metabolic ratios contralateral to the proposed 
surgery are associated with surgical failure. The predictive value of 
1H MRSI absolute metabolite concentrations for outcome in mesial 
temporal lobe epilepsy requires further investigation.
4. Diffusion tensor imaging (DTI)
DTI measures the molecular motion of water within brain 
tissue. The diffusivity (a measurement of the amplitude of the 
diffusional motion) and anisotropy (a measurement of the 
directionality of the motion) can be calculated from the DTI 
sequence. In the physiologic state, the diffusion of water is 
restricted by cell membranes. In the white matter, water diffusion 
is typically highly anisotropic. This characteristic is used in the 
reconstruction of white matter tracts using tractography 31) . The 
principal diffusion direction of the brain structure to be examined 
can be color-coded, resulting in color-coded maps or directionally 
encoded fractional anisotropy (FA) maps. In these maps, the fibers 
have been given different colors (blue for superior-inferior, green 
for anterior-posterior and red for left to right) depending on their 
direction of diffusion. DTI has also been investigated in terms 
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of its use in differentiating pathologic tissue from normal tissue 
based on differences in the anisotropic diffusion of water32). Several 
investigations using DTI have revealed higher diffusivity and 
lower anisotropy in the zones of FCD33), and in surrounding brain 
tissue that appeared normal in conventional MRI34). Although 
clinical experience with DTI in the presurgical evaluation of 
epilepsy is limited, two cases have been published so far where 
surgery was aided by DTI abnormalities35, 36). DTI may prove 
valuable for identifying epileptogenic foci as well as more optimally 
defining the extent of the lesion for surgical resection. In addition, 
the molecular diffusion of water is typically highly anisotropic 
in white matter tracts. This characteristic is being explored for 
reconstruction of fiber tracts using tractography37). The first data 
set of patients with FCD suggests that there are decreased fiber 
bundle densities adjacent to an area of FCD38). Fiber tractography 
will improve our understanding of brain pathology, especially 
that of white-matter abnormalities. Fiber tracking can be used 
in conjunction with functional MRI to analyze the anatomical 
connections and functional pathways for diagnostic purposes and 
presurgical planning39). The usefulness for DTI and tractography 
in various pathologies, including FCD, will be in the detection and 
full delineation of structural abnormalities, and in determining 
both the functional connectivity of a given area of the cortex and 
the spatial relationship between the lesion and important white 
matter tracts. This information may provide critical information 
for the planning of resective surgery in order to reduce functional 
morbidity. However, further improvements in techniques and 
stable post-processing analyses are needed to increase the utility of 
DTI in clinical applications. 
5. Functional MRI (fMRI)
Identification of eloquent areas of cortex responsible for speech, 
motor, and visual function, to assist in the surgical resection 
plan, can be obtained non-invasively through the use of fMRI. 
Functional MRI identifies changes in cerebral blood flow by 
measuring MRI contrast differences between oxygenated and 
deoxygenated hemoglobin. Increased cerebral blood flow is thought 
to represent functional activation of the surrounding cortex. 
Primary sensorimotor areas can be readily identified non-invasively 
by fMRI, and the results correlate well, but not perfectly, with 
those of cortical stimulation and evoked potentials40-43) .A major 
role of fMRI in epilepsy surgery work-up is in lateralizing language 
functions as a means to supplement or replace the intracarotid 
amobarbital test. A panel of tasks, including verbal fluency and 
language comprehension, has been advocated to increase the 
reliability of fMRI44). This modality also predicted language deficits 
following epilepsy surgery45) and could influence surgical planning. 
The correlation between fMRI with various neuropsychological 
tests and the intracarotid amybarbital procedure (IAP, Wada-
test) to predict memory decline after temporal lobectomy46) and to 
determine the language dominant hemisphere has been studied47). 
The main limitation of fMRI is its suboptimal specificity. A 
significant percentage of the cortical areas that are “activated” 
during an fMRI paradigm are dispensable for that specific 
function. Further work is therefore needed to clarify the role 
of fMRI in localizing eloquent cortex. At present, this method 
must be considered a research tool rather than part of the routine 
diagnostic workup of patients undergoing epilepsy surgery.
Conclusions
The likelihood of benefiting from surgical treatment was 
found to be significantly higher if localization with more imaging 
modalities were concordant with respect to the resected brain area 
Fig. 1. Convergent multimodal imaging in a 11-year-old boy with left temporal lobe epilepsy. Cortex thickening in the left 
temporal lobe is seen on the corresponding coronal T1W1 MRI. SISCOM demonstrated a cluster of hyperperfusion in the 
left temporal lobe, consistent with the patient’s ictal EEG. 18-FDG PET shows reduced metabolism in the overlying cortex. 
All imaging data were concordant with electroclinical and neuropsychological data and the patient underwent a neocortical 
temporal lobectomy. The patient has since remained seizure-free. Histopathology after temporal lobectomy showed FCD type 
2A.
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(Fig. 1, 2). Developments in imaging technology and digital post-
processing may increase the yield for imaging studies to detect the 
epileptogenic lesion and to characterize its connectivity within 
the epileptic brain. A better understanding of the concordant 
relationship between structural and functional neuroimaging data 
is expected to lead to new approaches in epilepsy surgery and will 
likely improve surgical management of a large number of patients 
suffering from intractable epilepsy.
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